Inclusion Of H.R. 3 Drug Price Control Measures In Infrastructure Bill May Negatively Impact Drug Industry

Aspects of H.R. 3 may be included in a pending infrastructure package. Should the infrastructure bill be enacted, with H.R. 3 price control measures that include international price indexing, it may have negative ramifications for the biopharmaceutical industry.

Read the full post at Forbes - Healthcare
Vote This Post DownVote This Post Up (No Ratings Yet)
Explore the Archive